期刊文献+

实时荧光定量PCR检测人apoM方法的构建 被引量:4

Establishing a method for quantitation of apolipoprotein M load using real-time fluorescence quantitative-PCR
原文传递
导出
摘要 目的建立检测人载脂蛋白M(apoM)的实时荧光定量PCR技术。方法采用Pri merExpress Versions2.0设计引物及Taq Man探针,检测apo M基因。将扩增的apo M基因片段纯化后与pMD19-T载体连接,克隆构建含apo M基因片段的重组质粒,作为定量检测apo M基因表达的标准品。结果PCR扩增产物经测序分析证实为apo M特异性片段。本法灵敏度为40copies/μl,线性范围为4.00×101~4.00×108copies/μl,相关系数为1.000,扩增效率E为90.5%,批间变异系数为6.38%~17.9%。结论成功建立了检测人apo M的实时荧光定量PCR方法,且该方法特异性好,灵敏度高。 Objective To develop a method for quantitation of apolipoprotein M(apoM)mRNA load using real-time fluorescence quantitative-PCR.Methods The primers and TaqMan probe targeted at signature and conserved sequence of apoM gene were designed by software "Primer Express Versions 2.0" and applied to detect the apoM mRNA levels.The apoM recombined plasmid was constructed by conventional molecular biological techniques,which was taken as the standard of apoM quantitative detection.The reaction system was optimized,and the sensitivity,specificity and reproducibility were evaluated.Results The amplification products were confermed as the specific fragment of apoM by DNA sequencing instrument.The results showed that the sensitivity,linear rang,the interassay coefficient of variation,the correlation coefficient of this assay were 4×101copies/μl,4.00×101~4.00×108 copies/μl,6.38%-17.9%,1.00,respectively.Conclusion The method for quantitation of apolipoprotein M(apoM)mRNA load has been established successfully with high sensitivity,specificity and stability and can be applied to quantify the apoM mRNA levels.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第4期425-428,共4页 Jiangsu Medical Journal
基金 国家自然科学基金(30570752) 江苏省自然科学基金(BK2008140)
关键词 人载脂蛋白M 实时荧光定量PCR Apolipoprotein M Real-time quantitative-PCR
  • 相关文献

参考文献14

  • 1Xu N, Dahlback B. A novel human apolipoprotein (apoM) [J]. J Biol Chem, 1999,274(44) : 31286-31290.
  • 2Zhang XY, Dong X, Zheng L, et al. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization[J]. Aeta Histochem, 2003,105 (1):67-72.
  • 3郑璐,徐宁,罗光华,张晓膺,董选,Peter Nilsson-Ehle.应用免疫组织化学方法检测载脂蛋白M在人类肝肾中的特异表达[J].中华检验医学杂志,2003,26(7):439-439. 被引量:12
  • 4Visvikis-Siest S,Marteau JB. Genetic variants predisposing to cardiovascular disease[J]. Curr Opin Lipidol, 2006, 17 ( 2 ) : 139-151.
  • 5Wolf rum C, Poy MN, Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis[J]. Nat Med, 2005, 11 (4): 418-422.
  • 6Luo G, Hurtig M, Zhang X, et al. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells[J]. Biochim Biophys Acta, 2005,1734 (2): 198-202.
  • 7Xu N, Nilsson-Ehle P, Hurtig M, et al. Both leptin and leptinreceptor are essential for apolipoprotein M expression in vivo [J]. Biochem Biophys Res Commun, 2004,321(4) : 916-921.
  • 8Xu N, Nilsson-Ehle P, Ahren B. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: partial reversal by insulin[J]. Biochem Biophys Res Commun, 2006, 342(4):1174-1177.
  • 9Zhang X,Jiang B, Luo G, et al. Hyperglycemia down-regulates apolipoprotein M expression in vivo and inv itro[J]. Biochim Biophys Acta, 2007,1771(7): 879-882.
  • 10Zhang X,Zhu Z,Luo G,et al. Liver X receptor agonist down-regulates hepatic apoM expression in vivo and in vitro[J]. Biochem Biophys Res Commun, 2008,371 (1) : 114-117.

二级参考文献10

  • 1Xu N, Dahlback B. A novel human apolipoprotein (apoM). J Biol Chem.1999. 274 : 31286-31290.
  • 2Duan J, Dahlbaek B, Villoutreix BO . Proposed lipocalin fold for apolipoprotein M based on bioinformaties and site-directed mutagenesis. FEBS Left,2001,499:127-132.
  • 3Xu N, Zhang XY, Dong X, et al. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-lalpha on the expression of apolipoprotein M in HepG2 cells. Biochem Biophys Res Commun ,2002,292:944-950.
  • 4Ni J,Abrahamson M,Zhang M,et al.Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family 2 cystatins[J].J Biol Chem,1997,272(16):10853-10858.
  • 5Sotiropoulou G,Anisowicz A,Sager R.Identification,cloning,and characterization of cystatin M,a novel cysteine proteinase inhibitor,down-regulated in breast cancer[J].J Biol Chem,1997,272(2):903-910.
  • 6Zeeuwen PL,Van IM,Jansen BJ,et al.Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands:a new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase[J].J Invest Dermatol,2001,116(5):693-701.
  • 7Ravi S,Jun Z,Daniel K,et al.Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells[J].Oncogene,2004,23(12):2206-2215.
  • 8Jun Z,Ravi S,Keppler D,et al.Cystatin M:A novel candidate tumor suppressor gene for breast cancer[J].Cancer research,2004,64(19):6957-6964.
  • 9Nadarajah V,Jean W,Susan M,et al.Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells-a preliminary study[J].Pathology Research and Practice,2005,200(11-12):753-762.
  • 10Nadarajah V,Jean W,Wolfgang Z.Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis[J].Oral Oncology,2003,39(6):559-568.

共引文献13

同被引文献35

  • 1李定彪,钱锦贤,洪志鹏.MTA1基因在非小细胞肺癌中的表达及其意义[J].中国肺癌杂志,2008,11(6):775-779. 被引量:5
  • 2张华,张明月,王洲,刘相燕,陈钢,刘凡英.肿瘤转移相关基因表达与Ⅰ期非小细胞肺癌预后的相关性[J].肿瘤,2010,30(10). 被引量:5
  • 3Yao J L, Ryan CK, Francis CW, et al. Tissue factor and VEGF expression in prostate carcinoma: a tissue microarray study [J]. Cancer Invest,2009,27(4):430-434.
  • 4Patty G, Hovington H, I..arue H, et,al. Tissue factor expres- sion correlates with disease-specific survival in patients with node-negative musele-inva.sive bladder eancer[J]. Int J Cancer, 2008,122(7) : 1592-1597.
  • 5Khorana AA, Ahrendt SA, Ryan CK, et al. Tissue factor expression,angiogenesis,and thrombosis in pancreatic cancer [J]. Clin Cancer Res, 2007,13 (10) : 2870-2875.
  • 6RonN Y,Post DE,Pieper RO,et al. PTEN and hypoxia regu- late tissue factor expression and plasma coagulation by glio- blastoma[J]. Cancer Res, 2005,65 (4) : 1406-1413.
  • 7Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alter- natively spliced human tissue factor: a circulating, soluble, thrombogenic protein[J]. Nat Med, 2003,9 (4) : 458-462.
  • 8van den Berg YW,van den Hengel LG,Myers HR,et al. Alternatively spliced tissue factor induces angiogenesis through integrin ligation[J]. Proc Natl Acad Sci USA, 2009, 106(46) : 19497-19502.
  • 9Mackman N. Alternatively spliced tissue factor - one cut too many[J]? Thromb Haemost, 2007,97 (1) : 5-8.
  • 10Szotowski B, Goldin-Lang P, Antoniak S, et al. Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy[J]. J Am CoU Cardiol, 2005,45 (7) : 1081-1089.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部